Next-generation sequencing technology combined with multiplexed barcoded samples of myelodysplastic syndromes reveals an abundance of target gene mutations
. Nagata Y. 05/21/11; 7618
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}